Mexico City - Only 25 percent of diabetics in the country follow a treatment and half of them are not controlled, since the medical prescription or the convenient dose are not determined.
The Landsteiner Scientific laboratory mentions in a statement that, for this reason, the development of genetic tests would allow better diabetes control.
It abounds that the genomic test can be performed with a blood sample, which allows to determine which treatment is the indicated and the way it should be administered, so that the results would improve.
In Mexico, 30 percent of people with type 2 diabetes do not respond to metformin, the most prescribed medication in the world to control this disease, because they have a genotype that leads to it, explained the director of new laboratory developments, Francisco Kuri Breña.
Therefore, the development of genetic tests allows better control from the beginning, providing the doctor with information to prescribe "second line" medications to those patients who know they will require them in advance.
"Now we are understanding the disease more from its origin and not from its symptoms, so that from the genome tests you can select the objective to be treated and which medication is the one that will correct it," Kuri Breña concluded.
